B& D Food Corp (LATF) 0.0009 $LATF Latteno Science to

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
B& D Food Corp (LATF) 0.0009 $LATF

Latteno Science to Use High Value Cannabinoid Extracts in 774 Billion USD Health, and Wellness Industries
Marketwired - Tue May 05, 4:37PM CDT
Latteno Food Corp. (OTC PINK: LATF) is pleased to announce Latteno Science will begin using high value cannabinoid extracts from Central America to sell to pharmaceutical, nutraceutical, and cosmeceutical industries. These cannabinoids will be used for health, and wellness products. In addition, Latteno Science will begin building an e-commerce site for sale of Latteno products in legal states. CEO John Pinheiro comments, "According to data from Euromonitor International, the sector witnessed sales of approximately $774 billion in 2014, and will have growth in 2015. With the quality of cannabinoid extracts from Central America, Latteno Science will have a competitive edge in the health, and wellness industry. We believe we are positioned to make a run at it by the 4th quarter of 2015. "After a lot of shareholder inquiries Latteno Food Corp. wants to reassure shareholders it has no plans for a reverse split. Company is in the process of exploring ways to maximize shareholder value.

Latteno Food Corp. Creates New Subsidiary Latteno Science for R&D of Cannabinoids in Central America
Marketwired - Fri Apr 24, 7:00AM CDT
Latteno Food Corp. (OTC PINK: LATF) is pleased to announce the formation of a new subsidiary Latteno Science Corp. that will conduct research and development of cannabinoids in Central America. The most common natural plant cannabinoids (phytocannabinoids) are: THC, cannabidiol (CBD), cannabigerol (CBG), cannabichromene (CBC), and cannabinol (CBN). CEO John Pinheiro comments: "We are very pleased to conduct research and development of cannabinoids with Latteno Science. Particular interest are the various strains of cannabinoids in Central America. It seems that the problem is that research facilities in the United States cannot duplicate the unique and complex strains of cannabinoids found in Central America. That is unfortunate because medical researchers from Central America are having surprisingly beneficial results in the treatment of various forms of cancer from cannabis from that region."

Reviews Of 15 Marijuana Stocks Before The Marijuana Investor Summit - Part V
Anthony Cataldo - at Seeking Alpha - Sat Apr 18, 6:09AM CDT

INSY: 59.00 (+0.17)

Pot Stock Crash Redux: $23.3B Loss?
Matthew Finston - at Seeking Alpha - Sun Mar 08, 12:42AM CST


48 Marijuana Stocks - A Post-Mortem: Part II
Anthony Cataldo - at Seeking Alpha - Wed Mar 04, 7:36AM CST

INSY: 59.00 (+0.17), FULL: 3.52 (-0.01), CARA: 9.99 (-0.14)

Marijuana Stocks: Seeking Liquidity
Matthew Finston - at Seeking Alpha - Mon Mar 02, 7:24AM CST


12 Marijuana Stocks For Your Do Not 'Buy And Hold' List - Part VII
Anthony Cataldo - at Seeking Alpha - Fri Jan 23, 1:56PM CST

INSY: 59.00 (+0.17), GWPH: 112.25 (-0.07), FULL: 3.52 (-0.01), LINE: 12.65 (-0.18), BAR: 28.94 (+0.05)

Latteno Outlines 2015 MMJ Growth Initiatives: US Legal Cannabis Market to Increase to $10.2 Billion by 2018
ACCESSWIRE - Wed Nov 12, 6:45AM CST
Initiatives Developed to Capitalize on Exponential GrowthTargeted Markets

Latteno's CannabeeSweets Division Introduces 5 New MMJ Edibles
eTeligis - Fri Oct 31, 10:36AM CDT
DENVER, CO, United States, via ETELIGIS INC., 10/31/2014 - - Latteno Food Corp. (OTC Pink: LATF) (PINKSHEETS: LATF), announced today that its wholly-owned subsidiary, CannabeeSweets, has released five new MMJ edibles to its products line. These new edibles are available immediately for local delivery to California's approved MMJ patients as well as selected dispensaries; and are expecting to provide additional revenue to the Company's MMJ Edibles initiatives.

Latteno Exceeds Record Revenue Pace: Q2 Revenue Approaches $4.0M
ACCESSWIRE - Tue Aug 12, 6:28PM CDT
DENVER, CO, United States / ACCESSWIRE / Latteno Food Corp. (OTC Pink: LATF) (PINKSHEETS: LATF) is pleased to announce that preliminary 2014 Q2 figures have exceeded 2013's Q2 record revenues. The continued gains can be attributed partly to the wholly-owned subsidiary company, Mekonza, and it's steady shipment growth of fresh seafood products both domestically and internationally. 2014Q2 3 month revenue increased to $3,988,418; and the Q2 6 month revenue increased to $7,784,538.

Latteno Set to Reap Benefits of Lucrative Colorado MMJ Grow Farm Business Model
ACCESSWIRE - Mon Aug 11, 10:45AM CDT
Unique Pilot Project with Licensed Grower to Ensure High Productivity

Latteno's Rx Harvest Collective Acquires S. Orange County MMJ Delivery Service
Marketwire - Mon Aug 04, 6:08AM CDT
Latteno Food Corp. (OTC Pink: LATF) (PINKSHEETS: LATF) announced today that its Rx Harvest Collective unit has recently acquired the South Orange County MMJ delivery service, MMJOC.com. This acquisition and extension of service areas are to include South Orange County beach cities and communities south of Highway 55. This will compliment Rx Harvest Collective's current MMJ delivery service customer base and delivery service area that covers North Orange County.

Latteno Signs Joint Venture Agreement With LA-Based Pre-ICO Greenlight Discount Pharmacy to Open MMJ Dispensary
eTeligis - Mon Jul 14, 6:39AM CDT
DENVER, CO, United States, via eTeligis Inc., 07/14/2014 - - Latteno Food Corp. (OTC Pink: LATF) (PINKSHEETS: LATF) is pleased to announce the signing of a Joint Venture Agreement with Los Angeles based Greenlight Discount Pharmacy, a Pre-ICO Prop D license holder, to co-open and co-own a dispensary in Arleta, CA.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Gwen Stefani Kicks Off OCVIBE's New Concert Hall

Updated Category News Views 101

A Homecoming Steeped in Nostalgia Orange County’s about to do a serious throwback, folks! Gwen Stefani is set to headline the opening concert at OCVIBE's spanking new concert hall in Anaheim on March 17, 2027. Curious choice for their opener? Hardly. This gal's practically woven into the county’s tapestry—her roots run deep here, enough to make even the casual music...

Continue Reading
Disney+ Teams Up with Tiff's: Blue Cookie Debut

Updated Category News Views 10

A Sweet Collaboration on the Horizon If somebody had told me that cookies could conjure up excitement equivalent to a TV show's new season, I'd have laughed. But here we are—Disney+ and Tiff's Treats are cooking up a storm with blue chocolate chip cookies to celebrate 'Percy Jackson and the Olympians' Season 3 premiere. The Cookie That Packs a Punch Forget ordinary...

Continue Reading
2GenPen's Patent Push: Transforming Credit Analysis

Updated Category News Views 111

Changing the Game in Credit Analysis When you hear about a company snagging a patent, it's usually a big whoop-de-do; but 2GenPen's latest achievement is making some serious waves. This isn't some 'pat-yourself-on-the-back' sort of news – it's got teeth in the world of finance. These folks just locked down their second U.S. patent, number 12,784,096, and it's all about...

Continue Reading
Tigo Energy Faces Lawsuit: Key Details for Investors

Updated Category News Views 49

Tigo Energy Inc.'s Troubles: A Stock Drop and Legal Woes You see, not every day do you wake up to find your investment taking a nose dive by 36.76%. But that’s exactly what happened to Tigo Energy, Inc. (NASDAQ: TYGO) after some shaky announcements. A Rollercoaster for Investors On August 4, 2026, Tigo hit investors with a one-two punch: revised financial outlook and...

Continue Reading
Lululemon Faces Class Action over Alleged Missteps

Updated Category News Views 19

Trouble Brewing for Lululemon Y'ever get that gut feeling when something doesn't smell right? Well, Lululemon Athletica (NASDAQ: LULU) investors are probably feeling that now. A class action's kicking up dust over what some are saying was a downright bumpy ride. The brainiacs at Robbins LLP urge those who've lost bucks riding the LULU train to step forward ahead of the...

Continue Reading
Pollo AI Unveils York AI: Automating Social Growth

Updated Category News Views 234

York AI Debuts as the New Kid on the Block Amid the hustle and bustle of a tech-savvy Singapore, Pollo AI’s latest offering, York AI, sashays onto the scene with the promise of putting social media growth on cruise control. We're talking about a digital sidekick that seems to know your online persona better than you do. It’s tailored for everyone from the small-time...

Continue Reading
Life Insurance: Evolving with Your Financial Journey

Updated Category News Views 32

Why Life Insurance Isn't Just a 'Set It and Forget It' Life insurance isn't some one-time deal you lock in and toss aside. Mike Newell, an insurance pro, highlights how life's shifts—whether in income, dependents, or debt—should drive tweaks to your coverage. As your life story unfolds, so too should the backbone of your financial security. Early Adulthood: Setting...

Continue Reading
Sinch Appoints Jonas Dahlberg as New CEO: A Strategic Move

Updated Category News Views 0

A Change at the Helm: Dahlberg Takes Charge Here we go, folks—Sinch, that global powerhouse in customer communications, just got itself a new captain. Jonas Dahlberg is now officially the CEO, after warming the acting CEO seat since June. This ain't your ordinary office shuffle. It's a calculated chess move in the high-stakes tech world. Dahlberg's Path to the Top This...

Continue Reading
LONGWELL's New Axial Fan Selection Guide Unveiled

Updated Category News Views 75

LONGWELL's New Fan Brochure Shakes Up Data Center Cooling Alright, let's cut to the chase. LONGWELL, the folks out in Ningbo who live and breathe HVACR and industrial fans, have dropped a new tool that’s going to have OEM engineers raising a glass. This twelve-page axial fan selection guide is a stroke of genius—or at least that's what those of us who've braved the...

Continue Reading
Akeso's Gumokimab Wins NMPA Approval for AS Treatment

Updated Category News Views 162

Gumokimab Approved: A New Dawn in AS Treatment Yeah, the biotech world shifts gears today as Akeso's gumokimab received the green light from China's National Medical Products Administration (NMPA). This approval for treating ankylosing spondylitis, or AS, isn't just another checkbox for Akeso; it's a game-changer in tackling this chronic inflammatory disease. Why should...

Continue Reading
" class="btn" href="https://investorshangout.com/blog/news?page=2">More News Articles